Stock Events

Stock Events

Icon 

$164.85
71
+$1.27+0.78% Friday 20:00
+$0.00+0%Friday 20:04After hours

Statistics

Day High
165.01
Day Low
164.47
52W High
203.91
52W Low
66.57
Volume
38,089
Avg. Volume
-
Mkt Cap
12.72B
P/E Ratio
74.21
Dividend Yield
-
Dividend
-

Upcoming

Earnings

28OctExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q2 2026
Next
2.55
2.98
3.42
3.85
Expected EPS
2.67828
Actual EPS
N/A

Financials

2.78%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
8.25BRevenue
229.34MNet Income

Analyst Ratings

181.27Average Price Target
The highest estimate is 209.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
64%
Hold
27%
Sell
9%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ICLR. It's not an investment recommendation.
Microsoft
20
MSFT
Alphabet
19
GOOGL
Amazon
17
AMZN
Adobe
17
ADBE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
IQVIA
IQV
Mkt Cap43.08B
IQVIA provides advanced analytics, technology solutions, and contract research services, making it a direct competitor in pharmaceutical development and healthcare data.
Charles River Laboratories International
CRL
Mkt Cap13.92B
Charles River Laboratories offers a variety of preclinical and clinical laboratory services, competing with ICON in drug development support.
Medpace
MEDP
Mkt Cap16.77B
Medpace is a full-service clinical contract research organization (CRO), offering a similar range of services as ICON, making it a competitor.

About

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Show more...
CEO
Barry Balfe
Employees
40100
Country
Ireland
ISIN
IE0005711209
WKN
000932242

Listings

XETRA
DE
IJF.XETRA
MX
MX
ICLRN.MX
STU
DE
IJF.STU
MU
DE
IJF.MU

0 Comments

Share your thoughts

FAQ

What is Icon stock price today?▼
The current price of ICLR is $164.85 USD — it has increased by +0.78% in the past 24 hours. Watch Icon stock price performance more closely on the chart.
What is Icon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Icon stocks are traded under the ticker ICLR.
Is Icon stock price growing?▼
ICLR stock has fallen by -3.04% compared to the previous week, the month change is a +0.82% rise, over the last year Icon has showed a -5.74% decrease.
What is Icon market cap?▼
Today Icon has the market capitalization of 12.72B
When is the next Icon earnings date?▼
Icon is going to release the next earnings report on October 28, 2026.
What were Icon earnings last quarter?▼
ICLR earnings for the last quarter are 2.56 USD per share, whereas the estimation was 2.55 USD resulting in a +0.57% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Icon revenue for the last year?▼
Icon revenue for the last year amounts to 8.25B USD.
What is Icon net income for the last year?▼
ICLR net income for the last year is 229.34M USD.
How many employees does Icon have?▼
As of September 05, 2026, the company has 40,100 employees.
In which sector is Icon located?▼
Icon operates in the Health & Wellness sector.
When did Icon complete a stock split?▼
The last stock split for Icon was on August 11, 2008 with a ratio of 1:1.
Where is Icon headquartered?▼
Icon is headquartered in Dublin, Ireland.